SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • June 19th, 2019 • Cell Source, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledJune 19th, 2019 Company Industry JurisdictionThis Sponsored Research Agreement (“Agreement”), effective as of the 28th day of November, 2018 (the “Effective Date”) is made by and between The University of Texas M. D. Anderson Cancer Center, (“MD Anderson”), a member institution of The University of Texas System (“System”), with a place of business at 1515 Holcombe Blvd., Houston, Texas, 77030, and Cell Source, a corporation with a place of business at 57 West 57th Street, Suite 400, New York, NY 10019. (“Sponsor”). MD Anderson and Sponsor hereinafter may be referred to each as a “Party” and collectively as the “Parties.”
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • April 1st, 2019 • Cell Source, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledApril 1st, 2019 Company Industry JurisdictionThis Sponsored Research Agreement (“Agreement”), effective as of the 28th day of November, 2018 (the “Effective Date”) is made by and between The University of Texas M. D. Anderson Cancer Center, (“MD Anderson”), a member institution of The University of Texas System (“System”), with a place of business at 1515 Holcombe Blvd., Houston, Texas, 77030, and Cell Source, a corporation with a place of business at 57 West 57th Street, Suite 400, New York, NY 10019. (“Sponsor”). MD Anderson and Sponsor hereinafter may be referred to each as a “Party” and collectively as the “Parties.”